Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.20
  • 52 Week Low: 2.35
  • Currency: UK Pounds
  • Shares Issued: 1,068.42m
  • Volume: 906,796
  • Market Cap: £74.79m
  • Beta: 0.03

Regulatory News

Grant of Share Options 05-May-2026 07:00 RNS
Q1 2026 Trading Update 01-May-2026 07:00 RNS
Total Voting Rights 30-Apr-2026 07:01 RNS
Enrollment in Phase II Clinical Trial for ACCRUFeR 27-Apr-2026 07:00 RNS
Audited results for year ended 31 December 2025 09-Apr-2026 12:30 RNS
Total Voting Rights 31-Mar-2026 07:03 RNS
EMA approves extension - to include adolescents 31-Mar-2026 07:00 RNS
Chinese NMPA Accepts MAA Submission for ACCRUFeR... 03-Mar-2026 07:00 RNS
Total Voting Rights 27-Feb-2026 07:00 RNS
FDA Grants additional Exclusivity for ACCRUFeR 09-Feb-2026 07:00 RNS
Total Voting Rights 30-Jan-2026 07:05 RNS
Approval for ACCRUFeR in China expected in Q1 2026 30-Jan-2026 07:00 RNS
Q4 2025 Trading Update 21-Jan-2026 07:00 RNS
Block listing 6 Monthly Return 02-Jan-2026 11:06 RNS
Total Voting Rights 02-Jan-2026 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 7.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.20
52 Week Low 2.35
Volume 906,796
Shares Issued 1,068.42m
Market Cap £74.79m
Beta 0.03

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 12-May-2026

Time Volume / Share Price
14:47 14 @ 7.10p
14:47 6,898 @ 7.10p
14:46 8,835 @ 7.10p
14:46 986 @ 7.10p
14:46 14 @ 7.10p

STX Key Personnel

CEO Anders Lundstrom

Top of Page